Finance

Lists
Why is WQ5 down 2.70%?
Dive Deeper
WQ5:FRA
Genflow Biosciences PLC
€0.018
-2.70%
(-0.00050) 1D
Oct 9, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for WQ5...
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
10.55M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.04
52-wk low
€0.01
No. of employees
5
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
10.55M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.04
52-wk low
€0.01
No. of employees
5
News stories
From web sources and news partners
About Genflow Biosciences PLC
CEO-
Employees5
Founded2020
Headquarters-
SectorBiotechnology
Websitegenflowbio.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
292.80K
292.80K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
555.24K
555.24K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-45.57K
-45.57K
227.16K
227.16K
Operating expense
632.78K
632.78K
209.86K
209.86K
Total operating expenses
632.78K
632.78K
209.86K
209.86K
Operating income
-339.97K
-339.97K
-209.86K
-209.86K
Other non operating income
-
-
-
-
EBT including unusual items
-339.97K
-339.97K
-210.12K
-210.12K
EBT excluding unusual items
-339.97K
-339.97K
-210.12K
-210.12K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
122.55K
122.55K
-17.29K
-17.29K
Net income
-339.97K
-339.97K
-210.12K
-210.12K
Net profit margin
-116.11%
-116.11%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-253.00
-253.00
Net interest expenses
-
-
-253.00
-253.00
Depreciation and amortization charges
547.00
547.00
-
-
EBITDA
-339.72K
-339.72K
-209.72K
-209.72K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps